دورية أكاديمية
P-137: ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results
العنوان: | P-137: ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results |
---|---|
المؤلفون: | Ghobrial, Irene, Rodríguez-Otero, Paula, Koh, Youngil, Martínez-López, Joaquín, Parmar, Gurdeep, Prince, Miles, Quach, Hang, de la Rubia, Javier, Hermansen, Emil, Hungria, Vania, Besisik, Sevgi Kalayoglu, Kim, Jin Seok, Leleu, Xavier, Peceliunas, Valdas, Schjesvold, Fredrik, Dubin, Franck, Devisme, Christine, Lepine, Lucie, Macé, Sandrine, Oprea, Codina, Mateos, María-Victoria |
المصدر: | Clinical Lymphoma Myeloma and Leukemia ; volume 21, page S109-S110 ; ISSN 2152-2650 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2021 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
مصطلحات موضوعية: | Cancer Research, Oncology, Hematology |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/s2152-2650(21)02264-3 |
الإتاحة: | https://doi.org/10.1016/s2152-2650Test(21)02264-3 https://api.elsevier.com/content/article/PII:S2152265021022643?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S2152265021022643?httpAccept=text/plainTest |
حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
رقم الانضمام: | edsbas.21E94867 |
قاعدة البيانات: | BASE |
DOI: | 10.1016/s2152-2650(21)02264-3 |
---|